Janssen Scientific Affairs, Llc

This study is a large registry that follows over 15,000 people with psoriasis to monitor the long-term safety of several treatments, including biologic drugs like infliximab, ustekinumab, and guselkumab. Participants receive their usual care while researchers track side effects, …